Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C

Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood

NCT02718573 ·Status: COMPLETED

Immunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C Virus

NCT00529321 ·Status: COMPLETED ·Phase: PHASE1

An Anti-viral Combination Study With Japanese Hepatitis C Infection (HCV) Subject

NCT01051414 ·Status: COMPLETED ·Phase: PHASE2

Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care

NCT01012895 ·Status: COMPLETED ·Phase: PHASE2

UNITY 3: A Japanese Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 in Subjects With Genotype 1 Chronic Hepatitis C

NCT02123654 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection

NCT02651194 ·Status: COMPLETED ·Phase: PHASE3

Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C Virus

NCT00800007 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects

NCT00559247 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in Andalusia

NCT02511496 ·Status: UNKNOWN

Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Patients

NCT01055821 ·Status: COMPLETED ·Phase: PHASE2

Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine

NCT00602784 ·Status: COMPLETED ·Phase: PHASE2

Leukapheresis for Research on HCV-Coinfected Patients

NCT00076427 ·Status: COMPLETED

A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C

NCT01675427 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C

NCT01447394 ·Status: WITHDRAWN ·Phase: PHASE3

A Multiple Ascending Dose Study of BMS-650032 in HCV Infected Subjects

NCT00722358 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection

NCT02023112 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Safety of ITX 5061 in Treatment-Naive Hepatitis C (HCV)-Infected Adults

NCT01165359 ·Status: COMPLETED ·Phase: PHASE1

Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)

NCT01121705 ·Status: COMPLETED ·Phase: PHASE3

A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients

NCT02569372 ·Status: COMPLETED ·Phase: PHASE1

Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected Patients

NCT01964742 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha-2b and Ribavirin) in Japanese Patients

NCT01016912 ·Status: COMPLETED ·Phase: PHASE2

Study of Daclatasvir (BMS-790052) and Simeprevir (TMC435) in Patients With Genotype 1 Chronic Hepatitis C Virus

NCT01628692 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1

NCT01508130 ·Status: COMPLETED

A Study of RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis C

NCT01371162 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1

NCT00790673 ·Status: COMPLETED ·Phase: PHASE1/PHASE2